{
    "nctId": "NCT03129555",
    "officialTitle": "The Danish Non-vitamin K Antagonist Oral Anticoagulation Study. A Cluster Randomized Study Comparing Safety and Efficacy of Edoxaban, Apixaban, Rivaroxaban and Dabigatran for Oral Anticoagulation in Patients With Venous Thromboembolism.",
    "inclusionCriteria": "* A diagnosis of VTE in outpatient clinic or as discharge diagnosis after hospitalization.\n* A claimed prescription of a NOAC from a Danish pharmacy within 14 days of discharge or outpatient clinic visit.",
    "exclusionCriteria": "* A prescription of a NOAC within 90 days prior to hospitalization or outpatient clinic visit for VTE.\n* Patients with NOAC preference apart from preference consistent with current cluster randomized NOAC.\n* Other contraindications mentioned in the \"Summary of Product Characteristics\" for the respective NOAC."
}